177 related articles for article (PubMed ID: 19762608)
21. [Prevalence of mild to moderate chronic kidney disease in the general population of Spain. Hortega study].
Simal F; Martín Escudero JC; Bellido J; Arzua D; Mena FJ; González Melgosa I; Alvarez Hurtado AA; Tabuyo MB; Molina A
Nefrologia; 2004; 24(4):329-32, 334, 336-7. PubMed ID: 15455492
[TBL] [Abstract][Full Text] [Related]
22. Chronic kidney disease and metabolic syndrome in a general Korean population: the Third Korea National Health and Nutrition Examination Survey (KNHANES III) Study.
Jang SY; Kim IH; Ju EY; Ahn SJ; Kim DK; Lee SW
J Public Health (Oxf); 2010 Dec; 32(4):538-46. PubMed ID: 20061374
[TBL] [Abstract][Full Text] [Related]
23. Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study.
Fox CS; Larson MG; Vasan RS; Guo CY; Parise H; Levy D; Leip EP; O'donnell CJ; D'Agostino RB; Benjamin EJ
J Am Soc Nephrol; 2006 Feb; 17(2):521-7. PubMed ID: 16382018
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults.
Viktorsdottir O; Palsson R; Andresdottir MB; Aspelund T; Gudnason V; Indridason OS
Nephrol Dial Transplant; 2005 Sep; 20(9):1799-807. PubMed ID: 15928100
[TBL] [Abstract][Full Text] [Related]
25. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.
Collins AJ; Vassalotti JA; Wang C; Li S; Gilbertson DT; Liu J; Foley RN; Chen SC; Arneson TJ
Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S71-7. PubMed ID: 19231764
[TBL] [Abstract][Full Text] [Related]
26. Metabolic syndrome is not a risk factor for kidney dysfunction in obese non-diabetic subjects.
Gatti A; Morini E; De Cosmo S; Maiani F; Mandosi E; Fallarino M; Morano S; Trischitta V
Obesity (Silver Spring); 2008 Apr; 16(4):899-901. PubMed ID: 18239564
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001.
Choi KM; Park HS; Han JH; Lee JS; Lee J; Ryu OH; Lee KW; Cho KH; Yoon D; Baik SH; Choi DS; Kim SM
J Hypertens; 2006 Aug; 24(8):1515-21. PubMed ID: 16877953
[TBL] [Abstract][Full Text] [Related]
28. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
29. Changes in the demographics and prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003).
Iseki K; Kohagura K; Sakima A; Iseki C; Kinjo K; Ikemiya Y; Takishita S
Hypertens Res; 2007 Jan; 30(1):55-62. PubMed ID: 17460372
[TBL] [Abstract][Full Text] [Related]
30. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
[TBL] [Abstract][Full Text] [Related]
31. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000.
Coresh J; Byrd-Holt D; Astor BC; Briggs JP; Eggers PW; Lacher DA; Hostetter TH
J Am Soc Nephrol; 2005 Jan; 16(1):180-8. PubMed ID: 15563563
[TBL] [Abstract][Full Text] [Related]
32. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome.
Cho GJ; Lee JH; Park HT; Shin JH; Hong SC; Kim T; Hur JY; Lee KW; Park YK; Kim SH
Menopause; 2008; 15(3):524-9. PubMed ID: 18467953
[TBL] [Abstract][Full Text] [Related]
33. Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction.
Marquezine GF; Oliveira CM; Pereira AC; Krieger JE; Mill JG
Int J Cardiol; 2008 Sep; 129(2):259-65. PubMed ID: 18036678
[TBL] [Abstract][Full Text] [Related]
34. Metabolic syndrome and the development of chronic kidney disease among 118 924 non-diabetic Taiwanese in a retrospective cohort.
Sun F; Tao Q; Zhan S
Nephrology (Carlton); 2010 Feb; 15(1):84-92. PubMed ID: 20377775
[TBL] [Abstract][Full Text] [Related]
35. Metabolic syndrome and risk of developing chronic kidney disease in Japanese adults.
Tozawa M; Iseki C; Tokashiki K; Chinen S; Kohagura K; Kinjo K; Takishita S; Iseki K
Hypertens Res; 2007 Oct; 30(10):937-43. PubMed ID: 18049025
[TBL] [Abstract][Full Text] [Related]
36. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
Whaley-Connell AT; Sowers JR; Stevens LA; McFarlane SI; Shlipak MG; Norris KC; Chen SC; Qiu Y; Wang C; Li S; Vassalotti JA; Collins AJ;
Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S13-20. PubMed ID: 18359403
[TBL] [Abstract][Full Text] [Related]
37. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem.
Iseki K
J Nephrol; 2008; 21(3):305-12. PubMed ID: 18587718
[TBL] [Abstract][Full Text] [Related]
38. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study.
Leoncini G; Viazzi F; Rosei EA; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Trimarco B; Volpe M; Deferrari G; Pontremoli R
J Hypertens; 2010 Jan; 28(1):156-62. PubMed ID: 19915481
[TBL] [Abstract][Full Text] [Related]
39. [Epidemiology of chronic kidney disease in the Democratic Republic of Congo: review of cross-sectional studies from Kinshasa, the capital].
Sumaili EK; Krzesinski JM; Cohen EP; Nseka NM
Nephrol Ther; 2010 Jul; 6(4):232-9. PubMed ID: 20409770
[TBL] [Abstract][Full Text] [Related]
40. Serum ferritin levels are associated with metabolic syndrome in postmenopausal women but not in premenopausal women.
Cho GJ; Shin JH; Yi KW; Park HT; Kim T; Hur JY; Kim SH
Menopause; 2011 Oct; 18(10):1120-4. PubMed ID: 21694651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
